Human Xenobiotic Nuclear Receptor PXR Augments Mycobacterium tuberculosis Survival.
Ella BhagyarajRavikanth NanduriAnkita SainiHedwin Kitdorlang DkharNancy AhujaVemika ChandraSahil MahajanRashi KalraDrishti TiwariCharu SharmaAshok Kumar JanmejaPawan GuptaPublished in: Journal of immunology (Baltimore, Md. : 1950) (2016)
Mycobacterium tuberculosis can evade host defense processes, thereby ensuring its survival and pathogenesis. In this study, we investigated the role of nuclear receptor, pregnane X receptor (PXR), in M. tuberculosis infection in human monocyte-derived macrophages. In this study, we demonstrate that PXR augments M. tuberculosis survival inside the host macrophages by promoting the foamy macrophage formation and abrogating phagolysosomal fusion, inflammation, and apoptosis. Additionally, M. tuberculosis cell wall lipids, particularly mycolic acids, crosstalk with human PXR (hPXR) by interacting with its promiscuous ligand binding domain. To confirm our in vitro findings and to avoid the reported species barrier in PXR function, we adopted an in vivo mouse model expressing hPXR, wherein expression of hPXR in mice promotes M. tuberculosis survival. Therefore, pharmacological intervention and designing antagonists to hPXR may prove to be a promising adjunct therapy for tuberculosis.
Keyphrases
- mycobacterium tuberculosis
- endothelial cells
- pulmonary tuberculosis
- mouse model
- hiv aids
- oxidative stress
- induced pluripotent stem cells
- randomized controlled trial
- free survival
- poor prognosis
- type diabetes
- adipose tissue
- cell death
- dendritic cells
- binding protein
- skeletal muscle
- mass spectrometry
- adverse drug
- signaling pathway
- peripheral blood
- human immunodeficiency virus
- single molecule